Trial Profile
Randomised phase III study testing nivolumab versus chemotherapy in first line treatment of PS 2 or elderly (more than 70 years old) patients with advanced non-small cell lung cancer.
Status:
Recruiting
Phase of Trial:
Phase III
Latest Information Update: 10 Jul 2016
Price :
$35
*
At a glance
- Drugs Nivolumab (Primary) ; Carboplatin; Gemcitabine; Paclitaxel; Pemetrexed; Vinorelbine
- Indications Adenocarcinoma; Large cell carcinoma; Non-small cell lung cancer; Squamous cell cancer
- Focus Therapeutic Use
- Acronyms eNERGY; Lena eNERGY
- 10 Jul 2016 New trial record